Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice

The antinociceptive effects of the carbon monoxide-releasing molecule tricarbonyldichlororuthenium (II) dimer (CORM-2) during chronic pain are well documented, but most of its possible side-effects remain poorly understood. In this work, we examine the impact of CORM-2 treatment on the lipoprotein p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Méndez-Lara, Karen Alejandra, Santos, David, Farré, Núria, Ruiz-Nogales, Sheila, Leánez, Sergi, Sánchez-Quesada, José Luis, Zapico, Edgar, Lerma, Enrique, Escolà-Gil, Joan Carles, Blanco-Vaca, Francisco, Martín-Campos, Jesús María, Julve, Josep, Pol, Olga
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6171880/
https://ncbi.nlm.nih.gov/pubmed/30286142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0204841
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados